Medicure (OTCMKTS:MCUJF – Get Free Report) announced its quarterly earnings data on Thursday. The company reported $999.00 EPS for the quarter, beating analysts’ consensus estimates of ($0.04) by $999.04, Zacks reports. Medicure had a negative net margin of 13.10% and a negative return on equity of 17.91%.
Medicure Stock Performance
Shares of Medicure stock remained flat at $0.96 during trading on Thursday. The company has a current ratio of 1.44, a quick ratio of 1.00 and a debt-to-equity ratio of 0.03. Medicure has a 12 month low of $0.60 and a 12 month high of $0.97. The company has a market capitalization of $10.06 million, a P/E ratio of -4.01 and a beta of 1.11. The firm’s 50 day simple moving average is $0.84 and its 200 day simple moving average is $0.84.
Medicure Company Profile
Medicure Pharmaceutical Corp. is a specialty pharmaceutical company focused on the development, manufacturing and commercialization of therapies in the cardiovascular and critical‐care markets. The company advances its business through a combination of in-licensing, acquisitions and strategic partnerships designed to build a diversified portfolio of prescription products that address unmet medical needs.
Headquartered in Montreal, Canada, Medicure operates in North America and selectively in Europe through licensing agreements with regional distributors.
Read More
Receive News & Ratings for Medicure Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medicure and related companies with MarketBeat.com's FREE daily email newsletter.
